Logo

Whatariff.com

Global Tariffs, Categorized

🇺🇸 United States
🌍 Select Country
📦 Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused

Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused

HS Code:

📦

Overview

The category 'Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused' (HS Code: 293349) includes chemical compounds with quinoline or isoquinoline structures, which are heterocyclic aromatic organic compounds. These compounds are widely used in the pharmaceutical industry for the production of antimalarial drugs, analgesics, and other medicinal products, as well as in the manufacture of dyes and agrochemicals. This category is critical to industries focused on health and agriculture, with significant research and development activities driving demand.

Total Trade Volume

USD 1.2 billion

Data from 2022

Source

United Nations Comtrade Database

Tariff Analysis

Average Rate

5.2%

Highest Rate

10% (applied by certain developing countries)

Lowest Rate

0% (under free trade agreements like EU-Japan EPA)

Common Restrictions

  • Import quotas in some countries to protect domestic pharmaceutical industries
  • Stringent quality control and certification requirements for pharmaceutical-grade compounds
  • Anti-dumping duties in specific regions to counter low-cost imports
  • Environmental regulations on production and waste disposal

Market Trends

Rising demand for antimalarial drugs

Increased export volumes from major producers like China and India due to ongoing global health initiatives targeting malaria-endemic regions

2021-2022

Shift towards sustainable production methods

Higher production costs but improved market access in regions with strict environmental regulations like the EU

2020-2022

Growth in generic drug manufacturing

Boosted trade in quinoline-based compounds as key intermediates for cost-effective generics

2019-2022

Recent Developments

New EU Regulation on Chemical Imports

The European Union introduced stricter import regulations for chemical compounds, including quinoline derivatives, to ensure compliance with REACH standards.

January 2023

Potential delays and increased costs for exporters to the EU, particularly for non-compliant suppliers

India's Export Incentive Scheme

India rolled out a new Production Linked Incentive (PLI) scheme to boost domestic manufacturing and export of pharmaceutical intermediates, including quinoline compounds.

April 2022

Strengthened India's position as a leading exporter, with a projected increase in trade volume by 15% over the next two years

US-China Trade Agreement Update

Negotiations between the US and China led to a temporary reduction in tariffs on certain chemical compounds, including those under HS 293349.

September 2022

Facilitated smoother trade flows between the two countries, benefiting US importers of Chinese quinoline compounds